MicroRNA-188-3p is involved in sevoflurane anesthesia-induced neuroapoptosis by targeting MDM2

Area of Science:

• Neuroscience
• Anesthesiology
• Molecular Biology

Background:

• Sevoflurane is a widely used inhalation anesthetic.
• Sevoflurane-induced neuroapoptosis and cognitive deficits are reported in animals, but mechanisms are unclear.
• Understanding these mechanisms is crucial for patient safety and developing interventions.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying sevoflurane-induced cognitive impairment.
• To investigate the role of microRNA-188-3p (miR-188-3p) in sevoflurane's effects.
• To identify potential therapeutic targets for sevoflurane-induced cognitive dysfunction.

Main Methods:

• Morris water maze test to assess spatial memory in rats.
• Quantitative polymerase chain reaction and Western blot to measure gene and protein expression.
• Luciferase assays to confirm microRNA targeting.
• Inhibition of miR-188-3p and p53 activity.

Main Results:

• Sevoflurane anesthesia induced spatial memory impairments in rats.
• Sevoflurane significantly increased miR-188-3p expression.
• Inhibition of miR-188-3p attenuated cognitive deficits and neuroapoptosis.
• miR-188-3p targets MDM2, regulating the MDM2-p53 pathway.
• The miR-188-3p-MDM2-p53 axis plays a critical role in sevoflurane-induced cognitive dysfunction.

Conclusions:

• The miR-188-3p-MDM2-p53 signaling pathway is implicated in sevoflurane-induced cognitive impairment.
• miR-188-3p may serve as a potential therapeutic target for mitigating sevoflurane's adverse cognitive effects.
• Further research into this pathway could lead to novel neuroprotective strategies in anesthesia.